Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

The search for a cure news

Show

From To
Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions in Adults

Scientists working to develop a cure for HIV infection sometimes need to conduct clinical trials in which participants are asked to temporarily interrupt ART, which contradicts the recommendations and guidelines for people with HIV under medical care.

Published
15 November 2018
From
TAG
STEPS V: HIV cure community workshop in Glasgow

STEPS, a community initiative to design the pathway to a long-term remission of HIV infection, has reached its 5th edition in Glasgow. This year the theme of the meeting that was held just before the opening of the HIV Drug Therapy Congress was ‘socio-behavioural science and ethics around HIV cure research’.

Published
01 November 2018
From
EATG
‘Fear overcome by love’: why I participated in HIV cure research

Researchers may not know me, but they know my blood cells. I am participant 2512 of the Observational Study of the Consequences of the Protease Inhibitor Era (SCOPE). I was told that my case of HIV was discovered at the earliest stage of infection in history. This is not the life accomplishment that I would want to be remembered for. However, when I found out, I did want to help my fellow human beings.

Published
22 October 2018
From
Journal of Virus Eradication
Second case of potential HIV eradication

One of the highlights of the BHIVA Autumn Conference, slipped in as a couple of slides at the end of the meeting, was that the UK might have a second potential case of HIV eradication (although this is one of the presentations is one that is not online).

Published
22 October 2018
From
HIV i-Base
Gilead and Aelix join forces to pursue HIV 'cure'

Gilead Sciences – already a giant in HIV therapy – has teamed up with Spanish biotech Aelix Therapeutics to try to develop a treatment regimen that would go beyond controlling the virus and provide an effective cure for the infection.

Published
18 October 2018
From
PMLiVE
Vedolizumab could be used to target latent HIV harboring in gut

Vedolizumab, a first-line treatment for inflammatory bowel disease that targets the alpha4beta7 protein, might be an important tool in the search for a cure for HIV, according to research published in Science Translational Medicine.

Published
04 October 2018
From
Healio
No 'reservoir': Detectable HIV-1 in treated human liver cells found to be inert

Novel study suggests HIV-1 still detectable in human liver macrophages unlikely to stay infectious after long-term antiretroviral therapy.

Published
02 October 2018
From
Science Daily
Powerful antibodies suppress HIV for months, could simplify treatment

Two studies in small numbers of people show for the first time that infusions of two powerful anti-HIV antibodies can completely suppress the virus for several months.

Published
28 September 2018
From
Science
Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously treated with antiretroviral therapy (ART). The study appears September 21st in the journal Molecular Therapy.

Published
24 September 2018
From
Science Daily
Investigators Uncover Details About A Rare Group of HIV Patients

A pair of new studies is shedding light on a rare, but scientifically important, group of people with HIV who are able to maintain viral control even after stopping antiretroviral therapy. Clues about this ability may help improve antiretroviral therapy, which currently most patients with HIV must receive for life.

Published
24 September 2018
From
MD Magazine

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.